RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo fo...
FY 2025
Mar 12, 2026
Q2 2025
Sep 5, 2025
Q1 2025
Apr 10, 2025
FY 2024
Mar 31, 2025
Q3 2024
Nov 29, 2024
